Terminated PHASE3 INTERVENTIONAL 3-arm NCT05254808

EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care (EXFOCY)

Sponsor: MJM Bonten

Updated 4 times since 2022 Last updated: Feb 27, 2022 Started: Sep 6, 2021 Primary completion: Feb 14, 2022 Completion: Feb 14, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient participating sites, and insufficient participants from participating sites mainly due to COVID-19 workload. The number of necessary participants could not be reached within the anticipated timelines and the allocated budget.

Other Urinary Tract Infections trials with similar outcome

NCT00731315 · Phase NA · Jul 2011

Browse all Urinary Tract Infections trials

Listed as NCT05254808, this PHASE3 trial focuses on Urinary Tract Infections and remains terminated or withdrawn. Sponsored by MJM Bonten, it has been updated 4 times since 2021, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Apr 2022 — Jul 2024 [monthly]

Terminated PHASE3
Mar 2022 — Apr 2022 [monthly]

Terminated PHASE3

First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MJM Bonten
Saltro
ZonMw: The Netherlands Organisation for Health Research and Development

Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Doorn, Netherlands
• Utrecht, Netherlands